GSK3B and infection: Pretreatment with H-89 markedly reduced p-GSK-3βSer9 protein level at 8 h post-infection compared to the infected control (54.8% decrease compared with infected control, P = 0.0006) (Fig. 4E), implying the role of PKA in inhibiting GSK-3β activity.